Amira Barkal

Amira Barkal

Company: Pheast Therapeutics

Job title: Co-Founder & Chief Executive Officer


Developing a Therapy to Target a Novel Macrophage Checkpoint 4:45 pm

Blocking CD24 signalling which is highly expressed on many tumors Targeting this ‘don’t eat me’ signal to mediate macrophage phagocytosisRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.